Company

Ahead together

We unite science, technology and talent to get ahead of disease together.

Close Video

Ahead Together

Getting ahead of disease is one of the most inspiring challenges there is on the planet.

Explore how we will positively impact the health of 2.5 billion people over the next 10 years

Getting ahead of disease in
80+
markets.
Careers
Innovation
4
global R&D centres.
R&D approach
Pipeline
60+
vaccines and medicines in development.
Innovation
Trust
1st
in the Access to Medicine Index for people in low- to middle- income countries.
Responsibility
Performance
~40
billion € in group turnover by 2021, including ~€29 billion in sales of pharmaceutical products and vaccines.
Investors

Belgium: the heart of GSK Vaccines

Belgium is home to three main vaccine sites for GSK (in Wavre, Rixensart and Gembloux), including the global headquarters of the group's vaccine division. This makes us the largest vaccine manufacturing network in the world.

We ask each of our almost 9 000 employees working in Belgium to share our mission and to think about how they can help all those patients who rely on our products. For that reason, every day our 1,800 scientists research and develop vaccines. And that is why we have been pioneering new solutions allowing us to make our products available to those who need them, wherever they live and whatever their ability to pay.

You might also like

Production site Wavre

At a glance

Belgium hosts 3 main vaccine sites for GSK, including the company's global headquarters of the vaccines division of the group.

Products

Learn more about our product portfolio.

Careers

By bringing together exceptional people in an inclusive environment, we can have a global impact.

Continue to Innovation